Skip to main content

MARSHALL WACE, LLP

Position in PRGO — PERRIGO Co plc

CIK 1318757 LONDON, X0

Position in PRGO

as of Mar 31, 2026 · filed May 15, 2026
Position Value
$1,910,860
+$1,707,335 QoQ
Shares Held
177,920
+1846.8% QoQ
Ownership
0.129%
of shares outstanding
% of Portfolio
0.00%
of 13F equity value
Holder Rank
not a current holder
Holding Since
Mar 2020
20 quarters on record
Voting authority Sole 0.ToString("F0")% Shared 100.ToString("F0")% None 0.ToString("F0")%

Common Shares in PRGO Over Time

Shares Held

Position Value (USD)

Position in Drug Manufacturers - Specialty & Generic

Healthcare · as of Mar 31, 2026

MARSHALL WACE, LLP holds $558,161,566 across 33 Drug Manufacturers - Specialty & Generic names. PRGO ranks #22 (0.3% of the industry book) .

# Ticker Company Shares Value (USD) Open

All Filings in PRGO

Export CSV
20 filing rows on record
Report Date Value (USD) Shares
2026-03-31 $1,910,860 177,920
2025-09-30 $203,525 9,139
2025-06-30 $204,354 7,648
2025-03-31 $1,355,312 48,335
2024-12-31 $4,290,046 166,863
2024-09-30 $728,748 27,783
2024-06-30 $364,656 14,200
2023-09-30 $4,524,311 141,606
2023-06-30 $2,277,433 67,082
2023-03-31 $28,899,813 805,682
2022-12-31 $14,732,163 432,155
2022-06-30 $64,176,871 1,581,880
2022-03-31 $15,290,028 397,867
2021-12-31 $12,802,534 329,114
2021-09-30 $232,390 4,910
2021-03-31 $1,699,254 41,988
2020-12-31 $467,771 10,460
2020-09-30 $8,931,560 194,545
2020-06-30 $15,408,225 278,781
2020-03-31 $5,275,040 109,691